Cargando…
Prognostic Value and Function of KLF5 in Papillary Thyroid Cancer
SIMPLE SUMMARY: This study was conducted to investigate the clinical significance and prognostic value of KLF5 in a large cohort of Middle Eastern PTC patients and explore its functional role and mechanism in PTC cell lines in vitro and in vivo. We found KLF5 over-expression in PTC patient cases and...
Autores principales: | Pratheeshkumar, Poyil, Siraj, Abdul K., Divya, Sasidharan Padmaja, Parvathareddy, Sandeep Kumar, Siraj, Sarah, Diaz, Roxanne, Begum, Rafia, Al-Sobhi, Saif S., Al-Dayel, Fouad, Al-Kuraya, Khawla S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825749/ https://www.ncbi.nlm.nih.gov/pubmed/33430300 http://dx.doi.org/10.3390/cancers13020185 |
Ejemplares similares
-
SUN-132 KLF5 Is a Poor Prognostic Marker and Therapeutic Target for Middle Eastern Papillary Thyroid Carcinoma
por: Al-Kuraya, Khawla S, et al.
Publicado: (2020) -
PD-L1 Is an Independent Prognostic Marker in Middle Eastern PTC and Its Expression Is Upregulated by BRAFV600E Mutation
por: Siraj, Abdul K., et al.
Publicado: (2021) -
CHD4 Predicts Aggressiveness in PTC Patients and Promotes Cancer Stemness and EMT in PTC Cells
por: Pratheeshkumar, Poyil, et al.
Publicado: (2021) -
Overexpression of the pro‐protein convertase furin predicts prognosis and promotes papillary thyroid carcinoma progression and metastasis through RAF/MEK signaling
por: Poyil, Pratheesh Kumar, et al.
Publicado: (2023) -
Overexpression of PARP is an independent prognostic marker for poor survival in Middle Eastern breast cancer and its inhibition can be enhanced with embelin co-treatment
por: Siraj, Abdul Khalid, et al.
Publicado: (2018)